Torrico, MC, Fernandez-Arevalo, A, Ballart, C, Solano, M, Rojas, E, Ariza, E, Tebar, S, Lozano, D, Abras, A, Gascon, J, Picado, A, Munoz, C, Torrico, F, Gallego, M. Tegumentary leishmaniasis by Leishmania braziliensis complex in Cochabamba, Bolivia including the presence of L. braziliensis outlier Tegumentary leishmaniasis in Cochabamba, Bolivia. Transboundary and Emerging Diseases. 2022; 69(4)DOI:10.1111/tbed.14228. PMID:34232559. IF:4.300(Q1/1D).

Gomez-Zorrilla, S, Becerra-Aparicio, F, Montesinos, IL, de Gopegui, ER, Grau, I, Pintado, V, Padilla, B, Benito, N, Boix-Palop, L, Farinas, MC, Penaranda, M, Gamallo, MR, Martinez, JA, Morte-Romea, E, Del Pozo, JL, Duran-Jorda, X, Diaz-Reganon, J, Lopez-Mendoza, D, Canton, R, Oliver, A, Ruiz-Garbajosa, P, Horcajada, JP. A Large Multicenter Prospective Study of Community-Onset Healthcare Associated Bacteremic Urinary Tract Infections in the Era of Multidrug Resistance: Even Worse than Hospital Acquired Infections?. Infectious Diseases and Therapy. 2021; 10(4)DOI:10.1007/s40121-021-00537-0. PMID:34626347. IF:6.119(Q2/3D).

Nemirosky, JL, Espelt, R, Grado, EL, Sobrino, J, Acera, A, Perez, J, Jensen, JS, Sanchez-Reus, F, Prim, N. Macrolide resistance in Mycoplasma genitalium in Catalonia, Spain: a 1 year prospective study. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2021; 76(10)DOI:10.1093/jac/dkab224. PMID:34278431. IF:5.758(Q1/2D).

Babich, T, Naucler, P, Valik, JK, Giske, CG, Benito, N, Cardona, R, Rivera, A, Pulcini, C, Fattah, MA, Haquin, J, MacGowan, A, Grier, S, Gibbs, J, Chazan, B, Yanovskay, A, Ben Ami, R, Landes, M, Nesher, L, Zaidman-Shimshovitz, A, McCarthy, K, Paterson, DL, Tacconelli, E, Buhl, M, Mauer, S, Rodriguez-Bano, J, Morales, I, Oliver, A, de Gopegui, ER, Cano, A, Machuca, I, Gozalo-Marguello, M, Martinez, LM, Gonzalez-Barbera, EM, Alfaro, IG, Salavert, M, Beovic, B, Saje, A, Mueller-Premru, M, Pagani, L, Vitrat, V, Kofteridis, D, Zacharioudaki, M, Maraki, S, Weissman, Y, Paul, M, Dickstein, Y, Leibovici, L, Yahav, D. Combination versus monotherapy as definitive treatment for Pseudomonas aeruginosa bacteraemia: a multicentre retrospective observational cohort study. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2021; 76(8)DOI:10.1093/jac/dkab134. PMID:33993273. IF:5.758(Q1/2D).

Aznar, ML, Espinosa-Pereiro, J, Saborit, N, Jove, N, Martinez, FS, Perez-Recio, S, Vitoria, A, Sanjoaquin, I, Gallardo, E, Llenas-Garcia, J, Pomar, V, Garcia, IO, Cacho, J, Freitas, LGD, San Martin, JV, Rodriguez, JFG, Jimenez-Fuentes, MA, De Souza-Galvao, ML, Tortola, T, Zules, R, Molina, I, Sanchez-Montalva, A. Impact of the COVID-19 pandemic on tuberculosis management in Spain. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES. 2021; 108DOI:10.1016/j.ijid.2021.04.075. PMID:33930543. IF:12.073(Q1/2D).

Caravaca-Fontan, F, Lucientes, L, Serra, N, Cavero, T, Rodado, R, Ramos, N, Gonzalez, F, Shabaka, A, Cabello, V, Huerta, A, Pampa-Saico, S, Gutierrez, E, Quintana, LF, Lopez-Rubio, ME, Draibe, J, Titos, JA, Fernandez-Juarez, G, De Jorge, EG, Praga, M. C3 glomerulopathy associated with monoclonal gammopathy: impact of chronic histologic lesions and beneficial effects of clone-targeted therapies. NEPHROLOGY DIALYSIS TRANSPLANTATION. 2022; 37(11)DOI:10.1093/ndt/gfab302. PMID:34677610. IF:6.100(Q1/2D).

Rodriguez-Temporal, D, Alcaide, F, Marekovic, I, O'Connor, JA, Gorton, R, van Ingen, J, Van den Bossche, A, Hery-Arnaud, G, Beauruelle, C, Orth-Holler, D, Palacios-Gutierrez, JJ, Tudo, G, Bou, G, Ceyssens, PJ, Garrigo, M, Gonzalez-Martin, J, Greub, G, Hrabak, J, Ingebretsen, A, Mediavilla-Gradolph, MC, Oviano, M, Palop, B, Pranada, AB, Quiroga, L, Ruiz-Serrano, MJ, Rodriguez-Sanchez, B. Multicentre study on the reproducibility of MALDI-TOF MS for nontuberculous mycobacteria identification. Scientific Reports. 2022; 12(1)DOI:10.1038/s41598-022-05315-7. PMID:35075208. IF:4.600(Q2/4D).

Bravo, MS, Berengua, C, Marin, P, Esteban, M, Rodriguez, C, del Cuerpo, M, Miro, E, Cuesta, G, Mosquera, M, Sanchez-Palomino, S, Vila, J, Rabella, N, Marcos, MA. Viral Culture Confirmed SARS-CoV-2 Subgenomic RNA Value as a Good Surrogate Marker of Infectivity. JOURNAL OF CLINICAL MICROBIOLOGY. 2022; 60(1)DOI:10.1128/JCM.01609-21. PMID:34669457. IF:9.400(Q1/2D).